TB-500 vs Wolverine — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
TB-500 is a synthetic fragment of Thymosin Beta-4, concentrated naturally in platelets and wound fluid. It promotes cell migration, angiogenesis, and systemic tissue repair via actin polymerization. Half-life of approximately 5 days enables twice-weekly dosing. WADA prohibited un...
Calculate TB-500 dose →Wolverine is a research peptide blend combining BPC-157 (5 mg) and TB-500 (5 mg) in a single vial. BPC-157 drives localized tissue repair and gut protection via angiogenesis; TB-500 promotes systemic cell migration and actin remodeling. Together they target overlapping healing pa...
Calculate Wolverine dose →| Parameter | TB-500 | Wolverine |
|---|---|---|
| Category | Healing & Recovery | Healing & Recovery |
| Research | Extensively Studied | Research Blend |
| Half-Life | ~5 days | BPC-157: 4-6 h; TB-500: ~5 days |
| Typical Dose | 2.5–5 mg | 500-1,000 µg |
| Frequency | 2–3× per week | 2-3x per week |
| Route | Subcutaneous | Subcutaneous |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.